comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 04:30:18 - browse：98259

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

entertainment

Wikipedia

WSS

Overprescribed: High cost isn't America's only drug problem

Gut bacteria may contribute to kidney autoimmunity, study finds

Overprescribed: High cost isn't America's only drug problem

Healthy food access boosts outcomes in two studies

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

What is STAT's opinion section for?

hotspot

comprehensive

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medical school prerequisites are outdated

Moonlake's readout produced a cash windfall. Risks remain

Alzheimer's risk factor APOE4 may be a distinct form of the disease

State Dept. review finds Biden bears some blame for Afghanistan failures

Overprescribed: High cost isn't America's only drug problem

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Continuity nursing helped my family in our darkest PICU moments

Gut bacteria may contribute to kidney autoimmunity, study finds

Wikipedia

Oral obesity drug from Viking Therapeutics hits key early target

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

A letter from the executive editor: STAT UnitedHealth investigation

UnitedHealth sued over use of algorithm in Medicare Advantage plans

What is STAT's opinion section for?

UnitedHealth sued over use of algorithm in Medicare Advantage plans

entertainment

focus

Wikipedia

entertainment